ArticleOncoimmunology2021

Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity.

Elizabeth R Sturgill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.